Comparison of Efficacy of Two Hybrid Regimens (10 days and 14 days )for Eradication of Helicobacter pylori Infectio

Not Applicable

• Conditions: gastric ulcer; gastric ulcer.

• Registration Number: IRCT2013112415510N1
• Lead Sponsor: Research Assistance, Mazandaran University Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients with endoscopic findings of gastric or duodenal ulcer or gastric and duodenal erosoin ; Helicobacter pylori infection ; patients older than 18 year and less than 80 years.

Exclusion criteria : pregnancy and lactation ; previously received Helicobacter pylori therapy ; patients received PPI (poroton poup inhibitor) or H2 RA (histamine 2 receptor antagonist) in last 2 weeks or within 4 weeks who received antibiotics ; history of surgery on the stomach ; Patients with confirmed advanced disease , severe cardiac, pulmonary , endocrine , chronic renal failure, chronic liver disease or have cancer ; The consumption of alcoholic beverages

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Helicobacter Pylori Infection. Timepoint: Before the intervention, and 12 weeks after intervention. Method of measurement: Before intervention, endoscopy and biopsy and RUT(Rapid urease Test), and after intervention endoscopy and biopsy and RUT(Rapid Urease Test ) and or UBT (Urea Breath Test ).

Secondary Outcome Measures

Name	Time	Method
Helicobacter Pylori Infection eradication rate, Hybrid regimes complication rate and patient compliance. Timepoint: 12 weeks after initiation of thrapy regimens. Method of measurement: Questionnaire and endoscopy and biopsy and or UBT (Urea Breath Test).